肿瘤患者医院感染革兰阳性球菌的分布与耐药性分析
[Abstract]:Objective to investigate the distribution of gram positive cocci in nosocomial infection of cancer patients and their resistance to common antibiotics, and to provide a basis for clinical rational use of antibiotics. Methods 172 cases of gram-positive cocci from the cancer prevention and control center of Zhongshan University in 2014 were investigated. All the specimens were used in French biological mailler. The VITEK-32 microbial identification system was used to identify the strains and analyze the drug resistance. The basic situation of the infected people, the distribution of the section, the distribution of the specimens and the drug resistance were analyzed with the software of EXCEL8.0 and WHONET5.4. The results showed that 172 strains of gram-positive cocci were isolated from the hospital infected patients, mainly from swabs, sputum and drainage. The higher isolation rate of the staphylococci was the radiotherapy department, ICU and the chest department, gram-positive cocci were mainly Streptococcus and Staphylococcus, 43.6% and 40.1%, respectively, the resistance rate of Streptococcus to erythromycin and sulfamethoxazole / trimethoprim was 85%, and the susceptibility rate to linezolid and vancomycin was 100%, and Enterococcus to clindamycin and erythromycin. The susceptibility rate of teicoplanin and tegacycline was 100%, and 1 strains of vancomycin resistant Enterococcus (VRE) were found. The resistance of Staphylococcus to penicillin and zoxicillin was 85%, and the susceptibility rate of linezolid and tenacycline was 100%; methicillin resistant Staphylococcus aureus (MRSA) and methicillin resistant coagulase negative grapes were found. The detection rates of staphylococci (MRCNS) were 60% and 89.8%. respectively. Conclusion the main specimens of gram positive cocci from hospital infection were mainly from the respiratory tract, mainly Streptococcus and Staphylococcus, the drug resistance was serious, the multidrug resistance was obvious, and the VRE was found. The clinical should be vigilant.
【作者单位】: 中山大学肿瘤防治中心医院感染管理科;中山医学院临床医学系;
【基金】:国家卫生计生委专项基金资助项目(1311200006402)
【分类号】:R446.5
【相似文献】
相关期刊论文 前10条
1 汪亮,姜兰斌;致乳腺感染的278株革兰阳性球菌及其药敏结果[J];临床检验杂志;2001年01期
2 吴敏;邓建平;姚春红;朱海波;;318株革兰阳性球菌体外耐药监测分析[J];中华医院感染学杂志;2007年03期
3 魏寿兰;严莹;盛茜;程惠;;加强监护病房革兰阳性球菌感染调查及耐药分析[J];实用药物与临床;2007年05期
4 周萍;张葵;张之烽;;革兰阳性球菌对利奈唑胺等抗菌药物体外药敏分析[J];临床输血与检验;2011年02期
5 孙庆国;王日中;彭慧颉;陈锋;;革兰阳性球菌引起腹腔感染的耐药状况分析[J];中国实验诊断学;2012年11期
6 张杏怡;袁园;周新;陈佰义;李群;丁星;;免疫缺陷患者医院革兰阳性球菌感染特性[J];上海医学;2013年01期
7 靖_g;薄剑;赵瑜;李红华;王书红;黄文荣;王全顺;;血液病房革兰阳性球菌感染病例回顾分析[J];中国实验血液学杂志;2013年05期
8 王一民;刘颖梅;曹彬;;革兰阳性球菌治疗的优化策略[J];传染病信息;2014年03期
9 陈淑兰;路娟;崔兰英;刘文博;宋熙瑶;赵金英;;临床常见革兰阳性球菌的分布与耐药性分析[J];中国实用内科杂志;2010年05期
10 凌春飞;陈志军;张学根;;常见革兰阳性球菌的分布与耐药性检测分析[J];当代医学;2014年18期
相关会议论文 前6条
1 李国钦;林梅溪;卢X;;本院3年间革兰阳性球菌的分离及药敏分析[A];第六届全国抗菌药物临床药理学术会议论文集[C];2006年
2 吴胜元;;革兰阳性球菌体外耐药监测与分析[A];湖北省暨武汉市微生物学会分析微生物专业委员会第十届第五次学术会议论文汇编[C];2008年
3 陈轼;康云平;;皮肤科细菌感染患者分离的革兰阳性球菌分布及药物敏感性分析[A];2006年浙江省检验医学学术年会论文汇编[C];2006年
4 路娟;刘文博;;我院8年间常见革兰阳性球菌的临床分布与耐药性分析[A];中华医学会第七次全国中青年检验医学学术会议论文汇编[C];2012年
5 徐镛男;张云;李林;王玉春;;临床分离革兰阳性球菌的分布及其耐药性监测[A];中华医院管理学会第十二届全国医院感染管理学术年会论文汇编[C];2005年
6 郝秀红;马聪;韩善桥;蒋学兵;;综合性医院2170株革兰阳性球菌对临床常用抗生素的耐药性监测[A];中华医院管理学会医院感染管理专业委员会第九届医院感染管理学术年会论文汇编[C];2002年
相关博士学位论文 前1条
1 徐晓刚;耐药革兰阳性球菌感染病原基因诊断研究[D];复旦大学;2004年
,本文编号:2147443
本文链接:https://www.wllwen.com/huliyixuelunwen/2147443.html